Jointly establish the Radioactive Pharmaceutical Innovation Industry Chain Alliance.
Lead drafting unit for Group Standard on Technical Specifications for Phase I Clinical Trials of Radiopharmaceutical Diagnostic Agents
Launch of DIA Nuclear Medicine Academic Community.
Jointly establish the VIQU Nuclear Medicine CRO Alliance.
Form a complete closed-loop nuclear medicine clinical service ecosystem.
Become a member unit of the Radioactive Pharmacy Branch of Chinese Nuclear Society.
Become the secretary-general site of Medical Innovation and Translation Professional Committee of China Productivity Society.
Creation of a subsidiary of medical device service.
Set up Shanghai Office covering south-estern China region.
Creation of CNS therapeutic area devision.
Entry of reproductive field by winning an ex vivo embryo screening study.
Initiation of Sino-US dual registry clinical study service.
Creation of Nuclear Medicine Service division.
